Riskpilot← Back to searchSign inGet full accessPerpeVit ApS
APSActiveCVR 40117784Cortex Park 26E, 1.Computer programming activities · NACE 6210Est. 2018— employeesperpevit.com
Revenue 2024
DKK 15K
-28% vs 2023
EBITDA margin
100.0%
+151% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
DKK 30K
+167% vs 2023
| Revenue | DKK 15K | -28% |
| EBITDA | DKK 15K | +151% |
| Net profit | DKK 30K | +167% |
| Total assets | DKK 290K | +11% |
| Equity | DKK 290K | +11% |
| Employees | — | — |
Legal name
PerpeVit ApS
CVR number
40117784
Legal form
Anpartsselskab
NACE code
6210 · Computer programming activities
Founded
17. december 2018
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse.
Company purpose
Selskabets formål er udvikling og kommercialisering af avancerede software produkter til brug for computerbaseret modellering af kemiske og biologiske processer på flere niveauer samt enhver virksomhed i hermed stående forbindelse.
Address
Cortex Park 26E, 1.
Email
admin@perpevit.com
Website
perpevit.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | -9 | 366 | 220 | -47 | 21 | 15 |
| Staff expenses | -0 | -61 | -80 | -50 | -50 | -0 |
| EBITDA | -9 | 306 | 140 | -97 | -29 | 15 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -9 | 306 | 140 | -97 | -29 | 15 |
| Net financials | 0 | -0 | -7 | -4 | -0 | -4 |
| Profit before tax | -9 | 306 | 133 | -101 | -29 | 11 |
| Tax | -2 | 68 | 30 | -22 | 16 | -19 |
| Net profit | -7 | 238 | 104 | -79 | -45 | 30 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 58 | 382 | 414 | 305 | 260 | 290 |
| Equity | 43 | 281 | 384 | 305 | 260 | 290 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 15 | 101 | 30 | 0 | 0 | 0 |
| Total debt | 15 | 101 | 30 | 0 | 0 | 0 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20192024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20192024
Return on equity
10.3%
This company
18.4%
Market median
+44% vs market
20192024
Net profit margin
200.5%
This company
8.1%
Market median
+2375% vs market
20192024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20192024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-12-17 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IS Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CyberMol ApS | Company | 66.7% | 66.7% | 2018 |
SCIENCE VENTURES DENMARK A/S | Company | 15.0% | 15.0% | 2018 |
| Individual | 10.0% | 10.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Syddansk Universitet (University of Southern Denmark)SCIENCE VENTURES DENMARK A/S
PerpeVit ApS (this company)Board members of PerpeVit ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ilya Solovyev | Management | 0 companies |
| Jens Kristian Damsgaard | Chairman | 0 companies |
| Vita Solovyeva | Board of Directors | 0 companies |